Crohn’s Disease Treatment

There's no cure for Crohn's disease, but there are many treatments available to help with symptom management, including medications, surgery, lifestyle changes, and complementary and integrative therapies.
The treatments your doctor recommends will depend on the severity and type of symptoms you're experiencing and what parts of your digestive tract are affected.
Here’s a look at the options.
What Are Some Treatments for Crohn’s Disease?
Next up video playing in 10 seconds
Medications for Crohn’s Disease
Medications that treat Crohn’s include:
Corticosteroids
- budesonide (Entocort EC or Uceris)
- methylprednisolone (Medrol)
- prednisone (Deltasone)
Immunomodulators
- azathioprine (Imuran)
- cyclosporine
- 6-mercaptopurine (Purinethol)
- methotrexate
- tacrolimus (Prograf)
Biologic and Biosimilar Therapies
Biologics are commonly used in moderate to severe disease and in mild disease when other treatments have not worked as well. They prevent inflammation by targeting proteins made by the immune system. They are given either as monotherapy or in combination with other medications and are delivered intravenously (IV) or by injection.
- adalimumab (Humira)
- certolizumab pegol (Cimzia)
- infliximab (Remicade)
- natalizumab (Tysabri)
- ustekinumab (Stelara)
- vedolizumab (Entyvio)
- guselkumab (Tremfya) (approved in October 2024 to treat Crohn’s)
- adalimumab-atto (Amjevita)
- infliximab-axxq (Avsola)
- infliximab-dyyb (Inflectra)
Janus Kinase (JAK) Inhibitors
In May 2023, the FDA approved the JAK inhibitor upadacitinib (Rinvoq) for adults with moderately to severely active Crohn’s disease who haven’t responded well to or can't tolerate one or more tumor necrosis factor (TNF) blockers.
Surgery for Crohn’s Disease
Commonly performed surgeries for Crohn's disease include:
Resection and Anastomosis
- Small Bowel Resection This is one of two procedures used to treat strictures (abnormal narrowing of the intestines). It involves removing part of your small intestine that’s been damaged by Crohn’s-related inflammation.
- Ileocecal Resection This involves removing damaged tissue from the terminal ileum, the end of the small intestine, and the cecum, the start of the large intestine.
- Large Bowel Resection This involves removing part of your colon (large intestine) that’s been damaged by Crohn’s-related inflammation.
Strictureplasty
Lifestyle Changes for Crohn’s Disease
Along with standard treatments, certain lifestyle changes can help you manage your symptoms.
Diet and Nutrition
- Fruits, like raspberries, bananas, or applesauce
- Vegetables, such as squash, green beans, cooked carrots, and cooked or blended leafy greens
- Foods containing omega-3 fatty acids, like tuna, mackerel, salmon, chia seeds, walnut butter, and flaxseed oil or meal
- Cooked and reheated starches, such as rice, oatmeal, potatoes, and sweet potatoes
- Alcohol
- Caffeinated beverages, like coffee
- Foods and drinks high in added sugars, like pastries or sodas
- Artificial sweeteners and sugar alcohols
- Foods high in fats, like fried foods
- Foods high in fiber, especially insoluble fiber, like Brussels sprouts or asparagus
- Foods and drinks high in lactose, like Cow’s milk or ice cream
- Spicy foods
- Red and processed meats, like steak, pork, bacon, hot dogs, deli meats, or sausages
- Coconut oil
- Palm oil
- Dairy fat
Other specific diets have been studied for Crohn’s disease, with varying levels of evidence to support their use. They include:
- Low-Residue Diet A low-residue diet involves limiting foods that are high in fiber, dairy, and whole grains. This helps reduce residue (undigested remains of fiber and other foods that lead to colonic waste) and lessen bowel irritation. A low-residue diet can reduce symptoms and help the bowel heal during an active flare-up.
- Mediterranean Diet The Mediterranean diet is a popular eating pattern that promotes the consumption of whole grains, fruits and vegetables, seafood, legumes, nuts, and healthy fats like olive oil. Some research suggests following the Mediterranean diet may help reduce IBD flares.
- Crohn’s Disease Exclusion Diet (CDED)?CDED is a less restrictive diet that combines whole foods and liquids (partial enteral nutrition). It can be helpful for both adults and children with active Crohn’s disease.
- Low-FODMAP Diet The low-FODMAP diet — an acronym for fermentable oligosaccharides, disaccharides, monosaccharides, and polyols — is a restrictive diet that involves temporarily eliminating certain sugars and fibers that are commonly not absorbed properly by the gut, and then gradually re-adding foods that don’t trigger GI symptoms for you. Research shows that, while it can help improve some gastrointestinal symptoms, it does not reduce inflammation in IBD.
Stress Management
Avoid Smoking
Complementary and Integrative Approaches for Crohn’s Disease
The Takeaway
- There's no cure for Crohn's disease, but there are therapies available to help with symptom management. They include medication, surgery, and lifestyle changes.
- The treatments your doctor recommends will depend on the severity and type of symptoms you're experiencing and what parts of your digestive tract are affected. It is important to establish care with a gastroenterologist to discuss all of the available options
- Tell your doctor before trying a complementary or integrative therapy for Crohn’s, especially if it’s a supplement, to make sure it doesn’t interact negatively with your Crohn’s medication.
Resources We Trust
- Mayo Clinic: Crohn’s Disease: Diagnosis & Treatment
- Cleveland Clinic: Crohn’s Disease
- American Gastroenterological Association: Crohn’s Disease Toolkit
- Crohn’s & Colitis Foundation: Medication Options for Crohn’s Disease
- American College of Gastroenterology: Crohn’s Disease
Additional reporting by Ajai Raj and Christina Vogt.
- Crohn’s disease: Diagnosis & treatment. Mayo Clinic. October 29, 2024.
- Medication Options for Crohn’s Disease. Crohn’s & Colitis Foundation.
- TREMFYA (guselkumab) demonstrates impressive results across biologic-na?ve and biologic-refractory patients in Crohn’s disease and ulcerative colitis. Johnson & Johnson. October 2024.
- FDA approves Lilly's Omvoh (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease. Lilly. January 15, 2025.
- IBD Medications List. Crohn’s and Colitis Foundation. 2025.
- FDA approves first oral treatment for moderate to severely active Crohn’s disease. Food and Drug Administration. May 18, 2023.
- Crohn’s Disease Treatment Options. Crohn’s & Colitis Foundation.
- Small and Large Bowel Resection. Crohn’s and Colitis Foundation. 2025.
- Stictureplasty. Crohn’s and Colitis Foundation. 2025.
- What Should I Eat? Crohn’s & Colitis Foundation.
- de Sire R et al. Exclusive Enteral Nutrition in Adult Crohn’s Disease: an Overview of Clinical Practice and Perceived Barriers. Clinical and Experimental Gastroenterology. December 29, 2021.
- Chicco F et al. Multidimensional Impact of Mediterranean Diet on IBD Patients. Inflammatory Bowel Disease. May 22, 2020.
- Peng Z et al. A Low-FODMAP Diet Provides Benefits for Functional Gastrointestinal Symptoms but Not for Improving Stool Consistency and Mucosal Inflammation in IBD: A Systematic Review and Meta-Analysis. Nutrients. May 15, 2022.
- González-Moret R et al. The effect of a mindfulness-based therapy on different biomarkers among patients with inflammatory bowel disease: a randomised controlled trial. Scientific Reports. March 19, 2020.
- Torres J et al. European Crohn’s and Colitis Organisation Topical Review on Complementary Medicine and Psychotherapy in Inflammatory Bowel Disease. Journal of Crohn’s & Colitis. March 2, 2019.
- Vitamin and Mineral Supplementation. Crohn's and Colitis Foundation. 2025.

Yuying Luo, MD
Medical Reviewer
Yuying Luo, MD, is an assistant professor of medicine at Mount Sinai West and Morningside in New York City.?She aims to deliver evidence-based, patient-centered, and holistic care for her patients.
Her clinical and research focus includes patients with disorders of gut-brain interaction such as irritable bowel syndrome and functional dyspepsia; patients with lower gastrointestinal motility (constipation) disorders and defecatory and anorectal disorders (such as dyssynergic defecation); and women’s gastrointestinal health.
She graduated from Harvard with a bachelor's degree in molecular and cellular biology and received her MD from the NYU Grossman School of Medicine. She completed her residency in internal medicine at the Icahn School of Medicine at Mount Sinai, where she was also chief resident. She completed her gastroenterology fellowship at Mount Sinai Hospital and was also chief fellow.

Lindsey Konkel
Author
Lindsey Konkel is an award-winning freelance journalist with more than 10 years of experience covering health, science, and the environment. Her work has appeared online and in print for Newsweek, National Geographic, Huffington Post, Consumer Reports, Everyday Health, Science, Environmental Health Perspectives, UCSF Magazine, American Association for Cancer Research, and others.
She previously worked as an editor and staff writer at Environmental Health News. She holds a master’s degree in journalism from NYU’s Science, Health and Environmental Reporting Program and a bachelor’s degree in biology from College of the Holy Cross.
Konkel lives in Haddon Township, New Jersey, with her husband, daughter, three cats, and dog. When she isn't writing, she handles social media and content marketing for a small veterinary clinic she started with her husband, Neabore Veterinary Clinic.